Caylor Johnson
Family Medicine · Augusta, GANPI 1700449956
Payments from drug & device makers
Across 87 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$175
- Lilly USA, LLC$132
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$128
- Pfizer$120
- Otsuka America Pharmaceutical, Inc.$117
- Novo Nordisk$113
- plus $691 from 18 others
What the payments were for
- Food & beverage$1,476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $175 |
| Lilly USA, LLC | 8 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $128 |
| Pfizer | 7 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $117 |
| Novo Nordisk | 7 | $113 |
| Dexcom, Inc. | 7 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $78 |
| Abbott | 5 | $75 |
| Bayer | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| AstraZeneca | 3 | $49 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Boston Scientific | 1 | $30 |
| Lundbeck LLC | 1 | $28 |
| Exact Sciences | 2 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Amgen | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,476 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 136 | $144,905 |
| OzempicSemaglutide | 116 | $130,063 |
| EliquisApixaban | 144 | $123,029 |
| FarxigaDapagliflozin Propanediol | 57 | $51,200 |
| LinzessLinaclotide | 60 | $46,903 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 50 | $37,284 |
| JardianceEmpagliflozin | 33 | $35,911 |
| Nucynta ErTapentadol Hcl | 12 | $23,746 |
| XareltoRivaroxaban | 23 | $20,348 |
| TrulicityDulaglutide | 19 | $18,743 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $16,255 |
| RexultiBrexpiprazole | 11 | $16,139 |
| Nurtec OdtRimegepant Sulfate | 11 | $11,685 |
| VascepaIcosapent Ethyl | 16 | $10,195 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 13 | $9,278 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $132 | $163,648155 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $120 | $137,055167 claims |
| Novo NordiskOzempic | $113 | $130,063116 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $49 | $88,484107 claims |
| AbbVieLinzess | $175 | $46,90360 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $117 | $16,13911 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $6,32412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Augusta
- Daron FerrisAugusta$186K
- David KriegelAugusta$36K
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.